NCT07825337

Brief Summary

To evaluate the feasibility and usability of Apple Vision Pro as an adjunct visualization and information display tool during ophthalmic surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
23mo left

Started Aug 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Aug 2026Aug 2028

First Submitted

Initial submission to the registry

August 30, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

August 30, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 17, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2028

Last Updated

September 17, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

August 30, 2026

Last Update Submit

September 12, 2026

Conditions

Keywords

Spatial computingAugmented RealityCataract SurgeryApple Vision ProHeads-up Display

Outcome Measures

Primary Outcomes (2)

  • Continuity of care

    Completion of surgery without device-related interruption that requires abandoning the surgery or conversion to an alternative procedure.

    1 year

  • Questionnaire

    XR Usability Questionnaire (XR-UQ) scores for each case.

    1 year

Study Arms (1)

Patient undergoing cataract surgery

Cataract surgery patients

Device: Apple Vision Pro Visualization System

Interventions

Apple Vision Pro as an adjunct intraoperative visualization and information display tool during ophthalmic surgery.\[

Patient undergoing cataract surgery

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Any patient having surgery performed who meets the inclusionary/exclusionary criteria at the Long Island Ambulatory Surgery Center, Brentwood, NY 11717

You may qualify if:

  • Adults aged 18 years or older.
  • Undergoing clinically indicated, elective ophthalmic surgery (e.g., cataract, anterior segment, retina) at a participating study site.
  • Able and willing to provide informed consent prior to participation.

You may not qualify if:

  • Prisoners or other vulnerable populations, unless specifically justified and approved by the IRB.
  • Inability to provide consent and no legally authorized representative available.
  • Cognitive impairment or language barriers precluding understanding of the consent, in the absence of a legally authorized representative.
  • Procedures where any additional OR equipment is judged by the surgeon to pose unacceptable risk.
  • Complex ocular pathology that could interfere with surgical visualization or increase procedural risk, including but not limited to lenticular zonule instability, previous ophthalmic surgery, corneal scarring, corneal opacity or edema, or active ocular surface infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Long Island Ambulator Surgery Center

Brentwood, New York, 11717, United States

RECRUITING

Related Publications (1)

  • Orione M, Rubegni G, Tartaro R, Alberghina A, Fallico M, Orione C, Russo A, Tosi GM, Avitabile T. Utilization of apple vision pro in ophthalmic surgery: A pilot study. Eur J Ophthalmol. 2025 Mar;35(2):715-721. doi: 10.1177/11206721241273574. Epub 2024 Aug 14.

Central Study Contacts

Kathy Lemier

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief Medical Officer

Study Record Dates

First Submitted

August 30, 2026

First Posted

September 17, 2026

Study Start

August 30, 2026

Primary Completion (Estimated)

August 30, 2027

Study Completion (Estimated)

August 30, 2028

Last Updated

September 17, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Novel technology with limited surgeons using 3D digital microscopes.

Locations